Abstract
To the Editor:
We read with great interest Drs. Baldo and Pham’s observations1 concerning our article2 and specifically their final claim that in selecting alternative cephalosporins in cephalosporin allergic subjects, “similarities and differences between R1 groups need to be noted but failure to do likewise for the R2 groups may lead to serious consequences for the occasional patient”.
Lingua originale | English |
---|---|
pagine (da-a) | 1428-1428 |
Numero di pagine | 1 |
Rivista | Journal of Allergy and Clinical Immunology |
Volume | 136 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- Drug allergy